Drug recall D-0877-2023
Product
Glycopyrrolate Tablets, USP, 1 mg, 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, NDC 13107-014-01
Reason for recall
Failed Impurities/Degradation Specifications
Lots and codes
Lot #: 01421038A1, Exp. Date 05/2023
Recall details
- Recalling firm
- Aurolife Pharma, LLC, Dayton, NJ
- Distribution
- Nationwide within the United States
- Recall initiated
- May 18, 2023
- Terminated
- August 28, 2024
Related products
- Glycopyrrolate – drug information
- NDC 13107-015 Glycopyrrolate · Glycopyrrolate 2 mg/1 · Aurolife Pharma LLC
- NDC 13107-014 Glycopyrrolate · Glycopyrrolate 1 mg/1 · Aurolife Pharma LLC